Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
about
Interplay Between Metabolism and Oncogenic Process: Role of microRNAsLong non-coding RNAs in colorectal cancerMolecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesisTumour-derived miRNAs and bone metastasisCirculating microRNAs are not eliminated by hemodialysisThe role of MALAT1 correlates with HPV in cervical cancer.miR-1 and miR-145 act as tumor suppressor microRNAs in gallbladder cancer.Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives.Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation.Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R.MiR-203 suppresses ZNF217 upregulation in colorectal cancer and its oncogenicity.Transcriptome analysis reveals distinct patterns of long noncoding RNAs in heart and plasma of mice with heart failure.Down-regulation of tissue microRNA-126 was associated with poor prognosis in patients with cutaneous melanoma.Small non-coding RNA deregulation in endometrial carcinogenesis.Novel Epigenetic CREB-miR-630 Signaling Axis Regulates Radiosensitivity in Colorectal CancerCooperative target mRNA destabilization and translation inhibition by miR-58 microRNA family in C. elegans.Surveillance for gastrointestinal malignanciesMALAT1 promoted invasiveness of gastric adenocarcinomamiR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cellsIsoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2'-deoxycytidine.Differentially Expressed miRNAs in Tumor, Adjacent, and Normal Tissues of Lung Adenocarcinoma.IntNetLncSim: an integrative network analysis method to infer human lncRNA functional similarity.Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities.miRNAs as mediators of drug resistance.Epstein-Barr Virus (EBV)-associated gastric carcinoma.Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution.Non-coding RNAs: biological functions and applications.MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer.MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines.Non-Coding RNAs in Hodgkin Lymphoma.Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes.Combined aberrant expression of microRNA-214 and UBC9 is an independent unfavorable prognostic factor for patients with gliomas.Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas.LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression.P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer.MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis.An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme.
P2860
Q26770381-D4FD86E7-56D5-428A-B137-89C9CE14A052Q26774282-21ED9851-4B1B-4010-B5E2-1271A98BDEC6Q26782044-A403F48F-DF08-40C6-B195-16CE27A600D0Q28086895-3F3BE373-AC24-4F3C-9C98-7447092BBB78Q28728683-E98E83C7-0039-4DE7-AB9E-24354C640310Q33727807-A52A1EB4-A5C1-4EBB-80B7-280AAA9CE9EAQ33802900-37C0BF4D-1D47-41BD-8BC6-93A824F2C6A4Q34559564-6C5F0480-DCC1-4D8E-A6BA-06BD1609D24EQ34599354-6CE270E8-A08E-4ACF-95C9-71C161E89CC9Q34664043-B5E594FD-CBCE-4BBA-9C2B-5B211DB0F374Q34722597-0F30C9E7-2CEE-408F-ADB7-F411305279B7Q35013647-71F35D66-6BAD-4FED-BF56-05365039E835Q35035814-747EC163-6558-4F2A-B432-5A0338B0E00BQ35644010-B1C1BC09-EA7B-486C-A1C2-32BAB4354393Q35741534-E4CED22D-1873-49C6-B8A1-5027B964CB44Q35742738-992F3515-026A-4690-9195-69487DA444EDQ36199571-47C502BD-6BF3-4E64-AF3C-ED033FAC83A8Q36214550-CAB6F00F-B373-46D6-B0ED-51ACE4168B20Q36246732-6C96AC44-8ABE-499B-B268-53EA5AD51CA6Q36451980-C108D567-B086-4E88-9DDC-CBD2A05C74C4Q36810277-10A8A27F-9143-44FE-A090-BC992CDD0646Q36928146-F74770B2-C47E-478B-B665-7D33A4B05B79Q37565302-5C2B1309-AB7C-478C-B9B4-019FC488A077Q37680071-35C08528-9257-49D8-A0E2-162E7E323C20Q37987661-5E210362-8891-4821-ACD1-142DF5D05CBBQ38037620-A463827C-C2BD-4EEF-A627-C8B63C3A41F9Q38076138-2D6BE217-9220-4634-9002-32F1B58BB85EQ38100689-0D319E6D-9BFC-40D8-9F47-AF2CF79C7378Q38283288-8BAA5342-C80A-41B9-A044-F6B74C41FFA2Q38396353-8B01AF4F-3F9F-4017-8261-B8AE886FBC1FQ38581149-63CF3009-6360-4C75-96F4-349BECFEE2AFQ39203809-2C1C579B-8F76-4066-8969-D35D782B07E3Q39336949-571DC0EC-2B11-41A9-88AA-038FEFDC74ADQ41592814-5C2D01A4-55BC-4956-96F8-47EB6118F076Q43699921-E7CFED9C-1C81-45DB-A3CE-915B23562928Q47113981-DF6335A0-F71C-4614-82CF-ADABA7FB925DQ47265726-75A4DF5B-B43C-4AF6-B1C3-2313BA0ED12BQ50898952-CA4A68A2-CE90-4219-A8E0-BE3354A3DDE8Q52641566-C20A1BFF-68E4-47FD-B283-41AF311F3746Q54537800-1396E736-14B3-4E70-BF36-C1B908C94FEF
P2860
Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
@en
Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
@nl
type
label
Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
@en
Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
@nl
prefLabel
Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
@en
Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
@nl
P2860
P1433
P1476
Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
@en
P2093
S Patrick Nana-Sinkam
P2860
P304
P356
10.1016/J.MOLONC.2011.10.003
P577
2011-10-31T00:00:00Z